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Summary: Plasma levels of the lysosomal enzyme, ß-N-acetyl-D-glucosaminidase (EC 3.2.1.30; 2-acetamido-
2-deoxy-ß-D-glucoside acetamidodeoxyglucohydrolase) were estimated 120 minutes after intravenous injec-
tion of zymosan in rats. Different groups of animals were investigated according to pretreatment with agents
influencing reticuloendothelial activity. Pretreatment for two days with the reticuloendothelial stimulating
agent, zymosan, or the reticuloendothelial suppressing agent, methyl palmitate, did not influence the basal
plasma levels of ß-N-acetyl-D-glucosaminidase.
In all groups after zymosan injection, plasma ß-N-acetyl-D-glucosaminidase activity was increased in compar-
ison with basal levels. The increase of enzyme activity was most pronounced after pretreatment with zymosan
aiid differed significantly from enzyme activity after pretreatment with methyl palmitate. Alcohol administra-
tion in combination with zymosan did not cause a further rise of ß-N-acetyl-£)-glucosaminidase activity in
normal rats nor in rats pretreated with zymosan.
The observations suggest that plasma levels of ß-N-acetyl-D-glucosaminidase in rats after a standardized
zymosan injection are related to the functional Status of the reticuloendothelial System (RES).
Einfluß von Stimulation und Depression des reticuloendothelialen Systems auf die katalytische Konzentration
der ß-N-Acetyl-D-glucosaminidase im Plasma: Eine experimentelle Untersuchung an Ratten
Zusammenfassung: Die katalytische Konzentration des lysosomalen Enzyms ß-N-Acetyl-D-glucosaminidase
(EC 3.2.1.30; 2-Acetamido-2^desoxy-ß-D-glucosid Acetamidodesoxyglucohydrolase) wurde 120min nach
intravenöser Injektion von Zymosän Im Plasma von Ratten bestimmt. Verschiedene Tiergruppen wurden
nach Vorbehandlung mit die reticuloendotheliale Aktivität beeinflussenden Stoffen untersucht. Vorbehand-
lung mit Zymosan als stimulierendem Agens oder Methylpalmitat als suppressivem Agens für zwei Tage
beeinflußte die basale katalytische Konzentration des Enzyms nicht.
Nach Injektion von Zymosan war die ß-N-Acetyl-D-glucosaminidase im Plasma im Vergleich zur basalen
katalytischen Konzentration bei allen Gruppen erhöht. Der Anstieg war nach Vorbehandlung mit Zymosan
sehr betont und unterschied sich deutlich von der katalytischen Konzentration nach Vorbehandlung mit Me-
thylpalmitat. Gäbe von Alkohol in Kombination mit Zymosan bewirkte keinen weiteren Anstieg des Enzyms
bei normalen oder mit Zymosan vorbehandelten Ratten.
*) This study was supported by grants from the Medical Faculty of the University of Lund, Lund, Sweden.
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Unsere Beobachtungen weisen darauf hin, daß die katalytische Konzentration von ß-N-Acetyl-D-glucos-
aminidase im Plasma von Ratten nach standardisierter Zymosaninjektion zum funktionellen Zustand des
reticuloendothelialen Systems in Beziehung steht.
Introduction
An increased serum level of ß-N-acetyl-D-glucos-
aminidase has been found in patients with different
diseases of the liver and in patients with acute ethan-
ol intoxication (1,2). The mechanisms leading to the
elevated level of lysosomal enzymes are not clear.
One possible reason could be an activation of body
macrophages leading to an increased synthesis and
secretion of lysosomal enzymes. Another reason
could be a defective clearance from the blood of ly-
sosomal enzymes, due to a decreased Kupffer cell
function.
It has been proposed that serum levels of lysosomal
enzymes could serve äs markers for macrophage ac-
tivation in mico (3). The release of lysosomal en-
zymes has been shown to be correlated with the pro-
cess of phagocytosis (4).
Zymosan, a yeast product derived from the cell wall
of Saccharomyces cerevisiae, has been demonstrated
to activate macrophages (5) and to produce a
marked hyperplasia and hyperfunction of the reticu-
loendothelial System (6, 7). Zymosan is phagocy-
tosed by macrophages, and the injection of zymosan
was followed by increased plasma levels of lysosomal
enzymes (8, 9). Methyl palmitate is a well known
suppressor of reticuloendothelial phagocytic activity
(10).
The aim of the present study was to investigate the
influence of reticuloendothelial zymosan-stimulation
and methyl palmitate-depression on the activity of ß-
N-acetyl-D-glucosaminidase in plasma after a single
dose of zymosan. The possibility that alcohol may
influence the release of ß-N-acetyl-D-glucosamini-
dase was also studied.
Materials and Methods r
Twenty five male Wistar rats, weighing 154—192g, were used.
The animals were divided into five groups according to the admin-
istered agents. All animals were fed on Standard food pellets and
water ad libitum.
Methyl palmitate (Sigma Co.) was prepared äs an emulsion by
sonification for 10 min in 50 g/l dextrose and l g/l Tween 20 at a
concentration of 400 g/l.
Zymosan (Sigma Co.) was suspended in 9 g/l saline at a concen-
tration of log/l.
Ten animals (groups A and E) did not receive any pretreatment.
Pretreatment was, given on two consecutive days with zymosan
(groups B and D) and methyl palmitate (group C) by intravenous
injection into the jugular vein linder light ether anesthesia.
Before the first injection, the jugular vein was cannulated and he-
parin-pläsma samples for basal levels of ß-N-acetyl-D^giucos·?
aminidase were collected. On the same day, zymosan was injected
into all the animals and blood samplihg (0.5 ml) was carried out
10,30, 60,90 and 120 min after the zymosan injection. This injec-
tion was preceded by an intravenous injection of alcohol in groups
D and E. Plasma was analysed for ß-N-acetyl-D-glucosaminidase
catalytic activity concentration using a method described else^
where (1). The coefficient of Variation for the method was below
10%.
Results are given äs meaii ± SEM. When testing for differences,
Studenfs t-test and the nonparametric Wilcoxon rank sum test
were used. Differences were regarded significant only when a p-
value of less than 0.05 was obtained in both tests.
Results v .. ,?
ß-N-Acetyl-D-glucosaminidase levels for the differ-
ent groups are depicted in table 1. After the zymosan
injection, a statistically significant increase of ß-N-
acetyl-D-glucosaminidase levels was seen in all
groups. No deviation of basal levels of ß-N-acetyl-
D-glucosaminidase was found in amnials pfetreated
with zymosan (B and D) or methyl palmitate (C),
when compared with the -pretreated groups (A
and E).
Tab. 1. Activity of ß-N-acetyl-D-glucosaminidase in serum before (basal) and after zymosan injection. Statistical significance for com-
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After 60 min, the level of ß-N-acetyl-D-glucos-
aminidase was significantly higher in the zymosan
pretreated rats (B) than in the methyl palmitate pre-
treated rats (C) with a p-value of 0.05 (Fig. 1). After
90 min, the enzyme level of the zymosan pretreated
rats was significantly higher than that in the control
(A) and the methyl palmitate pretreated rats (C)
with p-values of 0.05 in both comparisons (fig. 1).
The administration of alcohol (D and E) did not sig-
nificantly influence the rise of ß-N-acetyl-D-glucos-
aminidase activity when compared with the corre-






Fig. 1. ß-N-Acetyl-/)-ghicosaminidase activity after zymosan in-
jection into control animals (O—O), into animals pre-
treated with zymosan (Q—O) and methyl palmitate
( — ).
Discussion
Several methods are available for measurements of
reticuloendothelial function (11,12). These methods
are often based upon studies of the fate of injected
colloidal particles and often require technical equip-
ment such äs a scintillation camera and Computer
System.
A simple laboratory test that could reflect the func-
tional Status of the RES would be most valüable. For
this purpose lysosomal enzymes might be useful,
since it has been suggested that serum levels of these
enzymes could serve äs markers for macrophage ac-
tivation (3). Although resting macrophages release
lysosomal enzymes into their extracellular environ-
ments, this release is increased during macrophage
activation and phagocytosis (5, 8, 13, 14). On the
other band, increased serum levels of lysosomal en-
zymes after trauma have also been attributed to a
depression of RES function (15).
Zymosan given äs a single intravenous dose has been
shown to increase the reticuloendothelial function in
rats for at least 72 hours (7). Repeated administra-
tion of zymosan to rats has been shown to produce a
marked hyperplasia of Kupffer cells and mononu-
clear granuloma formation in the liver (6, 7, 16).
Serum activity of certain lysosomal enzymes such äs
ß-glucuronidase and acid phosphatase has been
shown to be considerably increased äs early äs
20 min after the injection of zymosan in rats (8). The
increase of serum lysosomal enzyme levels is, how-
ever, only transient and seems to exist only during
the phagocytosis of zymosan (8). The rapid increase
of lysosomal enzymes after zymosan injection proba-
bly results from the release of stored lysosomal en-
zymes (tissue forms). The turnover time of tissue
forms of ß-N-acetyl-D-glucosaminidase is known to
be very short when purified preparations are intrave-
nously injected into rats (15). This may explain why
the rise of serum ß-N-acetyl-D-glucosaminidase ac-
tivity in rats after zymosan injection is of short dura-
tion. In the present study the serum levels of ß-N-
acetyl-D-glucosaminidase remained increased for at
least 120 min over the basal levels, but were, howev-
er, normalized after 24 hours.
Increased plasma levels of cathepsin and acid phos-
phatase in rats after trauma have been attributed to a
depressed RES function, i.e. a decreased plasma
clearance by the Kupffer cells (15). In the present
study, the basal enzyme levels for pretreated rats
(zymosan or methyl palmitate) did not differ from
those in control animals. Basal enzyme levels could
thus not serve äs markers for the degree of reticu-
loendothelial activation or depression.
The present study revealed significantly higher plas-
ma levels of ß-N-acetyl-D-glucosaminidase after
zymosan injection in rats with an activated RES,
when compared with rats with a suppressed RES.
However, the enzyme response for the methyl pal-
mitate pretreated animals did not differ significantly
from that in controls. This observation suggests that
plasma levels of ß-N-acetyl-D-glucosaminidase after
zymosan injection are more dependent on the degree
of macrophage activation than on lysosomal enzyme
clearance.
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Alcohol administration did not significantly influ-
ence the rise of ß-N-acetyl-D-glucosaminidase levels
after zymosan injection in zymosan pretreated rats,
nor in non-pretreated rats. These findings are not in
accordance with earlier results concerning ß-N-acet-
yl-D-glucosaminidase activity in acute alcohol intox-
ication in man (2). Those patients had, however, in-
gested excessive amounts of alcohol for several
weeks.
In conclusion, isolated measurements of plasma ß-
N-acetyl-D-glucosaminidase activity in animals
without concomitant macrophage challenge are of
little value in predicting the Status of the reticuloen-
dothelial System. After a standardized zymosan in-
jection, the level of plasma ß-N-acetyl-D-glucos-
aminidase activity may be correlated with the degree
of activation of the reticuloendothelial System.
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